Naomi Herz

Health Technology Assessor

Ms Naomi Herz has experience researching health technology for its effectiveness (clinical and non-clinical), cost, and cost-effectiveness.

She previously worked in US health policy, researching the implications of medical device regulation on innovation. She also has experience in data mining, assessing the cost of medical device studies, and reviewing Phase 4 (post-approval) studies from an epidemiological perspective at the U.S. Food and Drug Administration.